Omicron subvariants resistant to key antibody treatments are increasing every week in the U.S.
October 28, 2022 Comments Off
The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S., a significant jump from the week prior when they made up about 16% of new cases.
Omicron subvariants resistant to key antibody treatments are increasing every week in the U.S.
The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S., a significant jump from the week prior when they made up about 16% of new cases.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender